{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:12:15Z","timestamp":1790154735124,"version":"4.0.1"},"reference-count":67,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and hemophagocytic lymphohistiocytosis (HLH) are life-threatening conditions characterized by immune dysregulation. Several reports have identified an overlap between these entities; however, clinical characteristics, triggers, and outcomes remain poorly defined. The objective of this study was to characterize the clinical features and outcomes of DRESS\/HLH overlap syndrome. Methods: We conducted a PRISMA-guided systematic review of PubMed, Embase, and MEDLINE. Studies were included if they reported cases meeting criteria for DRESS syndrome and HLH. Results: Thirty-six patients were included, 75% female and 27.8% pediatric. Initial misdiagnosis occurred in 30.6% and was associated with higher mortality (45.5% vs. 20.0%). Antibiotics were the most frequent triggers (36.1%) and 11.1% of patients had no trigger identified. Mean latency was 27.9 days for DRESS syndrome and 35 days for HLH, with shorter latency in antibiotic-associated cases. DRESS syndrome and HLH most commonly occurred sequentially (n = 22, 61.1%) and in 52.8% of cases DRESS preceded HLH. Fever and rash were present in 88.9%. Laboratory abnormalities included hyperferritinemia (91.7%), eosinophilia (77.8%), anemia (75.0%), and thrombocytopenia (75.0%). Hepatic involvement was nearly universal (94.4%), followed by renal involvement (36.1%). Viral reactivation was observed in 38.9%, multiorgan failure in 36.1%, and ICU admission in 19.4% of cases. Mortality was 27.8% and higher in steroid-refractory cases and those with multiorgan failure. Treatment included corticosteroids (97.2%), with IVIG (33.3%), etoposide (13.9%), and cyclosporine (5.6%) used in severe cases. Conclusions: DRESS-HLH overlap represents a severe hyperinflammatory syndrome with high mortality. Early recognition and escalation of therapy are essential to improve outcomes. This is the largest and most uniformly characterized cohort of DRESS\/HLH overlap reported to date, and the first to stratify mortality by diagnostic accuracy, temporal pattern, corticosteroid responsiveness, and multiorgan failure. Because the syndrome is rare and the evidence base consists almost entirely of single-case reports, multicenter collaboration and a prospective registry are needed to define incidence and optimal therapy.<\/jats:p>","DOI":"10.3390\/jcm15197383","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:14:39Z","timestamp":1790151279000},"page":"7383","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The DRESS\/HLH Overlap Syndrome: A Systematic Review of Clinical Features, Triggers, and Outcomes"],"prefix":"10.3390","volume":"15","author":[{"given":"Dorde","family":"Jevtic","sequence":"first","affiliation":[{"name":"Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5312-8812","authenticated-orcid":false,"given":"Igor","family":"Dumic","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA"},{"name":"Division of Hospital Medicine, Department of Medicine, Lahey Clinic, Burlington, MA 01805, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: A literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_3","first-page":"139","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): Incidence, pathogenesis and management","volume":"16","author":"Shiohara","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","article-title":"DRESS syndrome","volume":"81","author":"Descamps","year":"2014","journal-title":"Jt. Bone Spine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Khamashta","year":"2014","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/idr16020012","article-title":"Hemophagocytic Lymphohistiocytosis (HLH) in Patients with Tick-Borne Illness: A Scoping Review of 98 Cases","volume":"16","author":"Jevtic","year":"2024","journal-title":"Infect. Dis. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/ijd.15196","article-title":"Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: A review","volume":"60","author":"Yang","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2500\/aap.2017.38.4042","article-title":"A 28-year-old woman with fever, rash, and pancytopenia","volume":"38","author":"Ochoa","year":"2017","journal-title":"Allergy Asthma Proc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"A2988","DOI":"10.1016\/j.chest.2024.06.1801","article-title":"A Fatal Case of Drug Reaction with Esoinophilia and Systemic Symptoms (Dress): Hemophagocytic Lymphohistiocytosis (Hlh) Overlap Syndrome","volume":"166","author":"Reet","year":"2024","journal-title":"Chest"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.3748\/wjg.v17.i44.4928","article-title":"Acute liver failure caused by drug-induced hypersensitivity syndrome associated with hyperferritinemia","volume":"17","author":"Miyazaki","year":"2011","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Roman, K., and Tofil, N. (2023). Acute Liver Failure Following Lamotrigine Use: Drug Reaction, Hemophagocytic Syndrome, or Both?. Am. J. Respir. Crit. Care Med., A1915.","DOI":"10.1164\/ajrccm-conference.2023.207.1_MeetingAbstracts.A1915"},{"key":"ref_13","first-page":"E37","article-title":"Adult hemophagocytic syndrome secondary to dress syndrome: A case report","volume":"59","author":"Marques","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.25259\/IJDVL_925_20","article-title":"Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome associated with reactivation of Epstein-Barr virus leading to secondary hemophagocytic lymphohistiocytosis in an HLA-B*5801-negative patient","volume":"87","author":"Su","year":"2021","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_15","first-page":"23","article-title":"Carbamazepine-induced DiHS\/DRESS syndrome leading to hemophagocytic lymphohistiocytosis in a woman carrying the HLA-B*1301 gene","volume":"76","author":"Guo","year":"2021","journal-title":"Pharm.-Int. J. Pharm. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2147\/JAA.S505666","article-title":"Carbamazepine-Induced DRESS Complicated by HLH and VBDS: A Case Report","volume":"18","author":"Zhang","year":"2025","journal-title":"J. Asthma Allergy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jpc.16200","article-title":"Carbamazepine-induced liver injury in an 11-year-old female: Case report and review of the literature","volume":"59","author":"Amos","year":"2023","journal-title":"J. Paediatr. Child Health"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Pope, E.I., Au, H., Levy, D.M., and Verstegen, R.H.J. (2022). Case report: Drug reaction with eosinophilia and systemic symptoms (DRESS)-induced hemophagocytic disorder. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1023522"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaip.2013.04.001","article-title":"Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis","volume":"1","author":"Picard","year":"2013","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102455","DOI":"10.1016\/j.clinre.2024.102455","article-title":"DRESS syndrome associated with a hemophagocytic lympho-histiocytosis: A rare presentation of DILI induced by a nutritional supplement","volume":"48","author":"Lemmens","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/ced.14572","article-title":"Drug rash with eosinophilia and systemic symptoms complicated by haemophagocytic lymphohistiocytosis: Is screening required?","volume":"46","author":"Hussain","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/j.dld.2016.08.037","article-title":"Drug rash with eosinophilia and systemic syndrome (DRESS)\/hemofagocytic lymphohistocytosis (HLH) overlap in a child with acute liver failure presentation","volume":"48","author":"Mandato","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e28657","DOI":"10.1002\/pbc.28657","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)-associated hemophagocytic lymphohistiocytosis (HLH), an important and underrecognized HLH mimic: A case report","volume":"68","author":"Abbott","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5021\/ad.2018.30.1.71","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms Associated with Reactivation of Epstein-Barr Virus and\/or Cytomegalovirus Leading to Hemophagocytic Syndrome in One of Two Patients","volume":"30","author":"Liang","year":"2018","journal-title":"Ann. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.18176\/jiaci.0904","article-title":"Drug-Induced Hypersensitivity Syndrome with Hemophagocytic Lymphohistiocytosis Related to Piperacillin-Tazobactam: A Case Report","volume":"33","author":"Shen","year":"2023","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/apm.12694","article-title":"Erdheim-Chester disease with unusual clinicopathological features complicated by DRESS syndrome, disseminated Cytomegalovirus infection and hemophagocytic lymphohistiocytosis","volume":"125","author":"Gaspar","year":"2017","journal-title":"APMIS Acta Pathol. Microbiol. Immunol. Scand."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaip.2017.08.041","article-title":"Fatal DRESS syndrome under tocilizumab treatment for seronegative polyarthritis","volume":"6","author":"Seve","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00228-019-02809-8","article-title":"Fatal sulfasalazine-induced DRESS complicated by HHV-6 reactivation and hemophagocytic lymphohistiocytosis","volume":"76","author":"Ammar","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_29","first-page":"262","article-title":"Hemophagocytic Lymphohistiocytosis Overlapping Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Retrospective Study and a Brief Review of the Literature","volume":"34","author":"Fadhel","year":"2023","journal-title":"Dermat. Contact Atopic Occup. Drug"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2133.1997.tb03795.x","article-title":"Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome","volume":"137","author":"Descamps","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e262809","DOI":"10.1136\/bcr-2024-262809","article-title":"Leflunomide-induced drug reaction eosinophilia systemic symptoms and haemophagocytic lymphohistiocytosis overlap syndrome with rheumatoid arthritis","volume":"18","author":"Sebastian","year":"2025","journal-title":"BMJ Case Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdcr.2022.11.006","article-title":"Minocycline induced drug rash with eosinophilia and systemic symptoms complicated by hemophagocytic lymphohistiocytosis","volume":"32","author":"Zhao","year":"2023","journal-title":"JAAD Case Rep."},{"key":"ref_33","first-page":"e100848","article-title":"Navigating a Dual Hyperinflammatory State: Overlap of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) and Secondary Hemophagocytic Lymphohistiocytosis (HLH) in a Child","volume":"18","author":"Gupta","year":"2026","journal-title":"Cureus"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S1073","DOI":"10.14309\/01.ajg.0001147564.59438.e7","article-title":"S5026 Sulfasalazine-Induced DRESS and Secondary Hemophagocytic Lymphohistiocytosis (HLH) in Crohn\u2019s Disease","volume":"120","author":"Saffran","year":"2025","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"V\u00e9lez-Tirado, N., Araque-Mu\u00f1oz, P., and Amador-Patarroyo, J. (2022). Secondary Hemophagocytic Syndrome: A Severity Expression of Disease in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms (Dress). Case report. Int. J. Dermatol. Venereol.","DOI":"10.1097\/JD9.0000000000000226"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yan, S., Gan, Y.-T., Li, J.-J., Sheng, Y., and Shi, B.-J. (2026). Severe DRESS syndrome with hemophagocytic lymphohistiocytosis and cryptococcal meningitis: A case report and diagnostic challenge. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1703040"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.humpath.2014.04.019","article-title":"Severe enterocolitis associated with antiepileptic-induced drug reaction with eosinophilia and systemic symptoms","volume":"45","author":"Swanson","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/2229-5151.152349","article-title":"Severe hemophagocytic lymphohistiocytosis as a complication of drug-induced hypersensitivity syndrome","volume":"5","author":"Gauchan","year":"2015","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10067-007-0753-4","article-title":"Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus","volume":"27","author":"Komatsuda","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"ref_40","first-page":"e69503","article-title":"Toxic Epidermal Necrolysis Superimposed on Severe Drug Rash with Eosinophilia and Systemic Symptoms Complicated by Fatal Hemophagocytic Lymphohistiocytosis: A Case Report","volume":"16","author":"Swaminathan","year":"2024","journal-title":"Cureus"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e265178","DOI":"10.1136\/bcr-2025-265178","article-title":"X-linked lymphoproliferative syndrome type 1 presenting as DRESS-HLH overlap syndrome","volume":"18","author":"Periyanayagam","year":"2025","journal-title":"BMJ Case Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Aromataris, E., and Munn, Z. (2020). Chapter 7: Systematic reviews of etiology and risk. JBI Manual for Evidence Synthesis, JBI. Available online: https:\/\/jbi.global\/critical-appraisal-tools.","DOI":"10.46658\/JBIRM-17-01"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100673","DOI":"10.1016\/j.waojou.2022.100673","article-title":"DRESS syndrome: A literature review and treatment algorithm","volume":"16","author":"Calle","year":"2023","journal-title":"World Allergy Organ. J."},{"key":"ref_44","unstructured":"Konkol, S., Killeen, R.B., and Rai, M. (2026). Hemophagocytic Lymphohistiocytosis. StatPearls, StatPearls Publishing."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaci.2015.06.048","article-title":"Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry","volume":"137","author":"Cetica","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2023.07.023","article-title":"Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants","volume":"153","author":"Bloch","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.seizure.2017.10.018","article-title":"HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population","volume":"53","author":"Ksouda","year":"2017","journal-title":"Seizure"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjd.12389","article-title":"HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Portuguese population","volume":"169","author":"Coutinho","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e251255","DOI":"10.1136\/bcr-2022-251255","article-title":"Haemophagocytic lymphohistiocytosis (HLH) in an adult following treatment with trimethoprim\/sulfamethoxazole","volume":"15","author":"Zimilover","year":"2022","journal-title":"BMJ Case Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Diaz, L., Jauzelon, B., Dillies, A.-C., Le Souder, C., Faillie, J.-L., Maria, A.T.J., and Palassin, P. (2023). Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051985"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1182\/blood-2024-202475","article-title":"Lamotrigine and Anti-Epileptic Medications in HLH: A Systematic Review","volume":"144","author":"Gummadi","year":"2024","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/1744666X.2026.2718332","article-title":"Lamotrigine and other therapy-associated HLH syndromes: A review","volume":"22","author":"Gummadi","year":"2026","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"AB206","DOI":"10.1016\/j.jaci.2022.12.643","article-title":"A Shorter Time to DRESS\u2014Redefining beta-lactam associated drug reaction with eosinophilia and systemic symptoms","volume":"151","author":"James","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study","volume":"82","author":"Soria","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Radovanovic, M., Jevtic, D., Calvin, A.D., Petrovic, M., Paulson, M., Prada, L.R., Sprecher, L., Savic, I., and Dumic, I. (2022). \u2018Heart in DRESS\u2019: Cardiac Manifestations, Treatment and Outcome of Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Systematic Review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030704"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Jevtic, D., Dumic, I., Nordin, T., Singh, A., Sulovic, N., Radovanovic, M., Jecmenica, M., and Milovanovic, T. (2021). Less Known Gastrointestinal Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review of the Literature. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184287"},{"key":"ref_58","first-page":"31","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"28492","DOI":"10.1038\/s41598-024-69054-7","article-title":"Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)","volume":"14","author":"Chan","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.12998\/wjcc.v7.i6.705","article-title":"Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome","volume":"7","author":"Shear","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"da Silva, M.D., Domingues, S.M., Oluic, S., Radovanovic, M., Kodela, P., Nordin, T., Paulson, M.R., Joksimovi\u0107, B., Adetimehin, O., and Singh, D. (2023). Renal Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review of 71 Cases. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144576"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jamadermatol.2020.0048","article-title":"Evaluation of Cyclosporine for the Treatment of DRESS Syndrome","volume":"156","author":"Nguyen","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.anai.2024.08.509","article-title":"A CASE of RECALCITRANT DRESS SYNDROME RESPONSIVE to COMBINATION THERAPY with BENRALIZUMAB and UPADACITINIB","volume":"133","author":"Zhang","year":"2024","journal-title":"Ann. Allergy. Asthma. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Rubin, L., Talmon, A., Ribak, Y., Kessler, A., Martin, Y., Haran, T.K., Shamriz, O., Adini, I., and Tal, Y. (2023). Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1134178"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/S0735-1097(17)35740-6","article-title":"Drug rash with eosinophilia and systemic symptoms (dress) syndrome associated eosinophilic myocarditis treated with tofacitinib an oral janus (jak) kinase inhibitor","volume":"69","author":"Azari","year":"2017","journal-title":"JACC"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society","volume":"28","author":"Henter","year":"1997","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_67","first-page":"e103346","article-title":"Trends in Mortality Rates from Hemophagocytic Lymphohistiocytosis in the United States from 2010 to 2023","volume":"18","author":"Locke","year":"2026","journal-title":"Cureus"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7383\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:56:56Z","timestamp":1790153816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":67,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197383"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197383","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}